Actively Recruiting

Age: 18Years +
FEMALE
NCT06421181

Hemodynamic Effects of Anesthesia Induction

Led by Kliniken Essen-Mitte · Updated on 2025-01-15

30

Participants Needed

1

Research Sites

76 weeks

Total Duration

On this page

Sponsors

K

Kliniken Essen-Mitte

Lead Sponsor

H

Heinrich-Heine University, Duesseldorf

Collaborating Sponsor

AI-Summary

What this Trial Is About

The idea of that project is to characterize the hemodynamic changes of a daily used clinical intervention (induction of anesthesia) in a highly controlled environment by two hemodynamic monitoring devices. The aim is an advanced hemodynamic profiling of this intervention and additionally screen for changes in flow patterns in an exploratory fashion. Both devices complement one another in their hemodynamic profiling ability. One device is a continuous monitoring with instant traceable changes and the other an intermittent point-of-care ultrasound/echocardiography device with advanced possibilities for differential diagnostics. A second purpose is to test the possibility to implement advanced echocardiography in a point-of-care approach during anaesthesia induction and evaluate the time and quality of a comprehensive analysis by a not-certified anaesthetists with an echocardiography device with features of artificial intelligence versus a certified expert.

CONDITIONS

Official Title

Hemodynamic Effects of Anesthesia Induction

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing elective laparotomy in the hospital Evangelische Kliniken Essen-Mitte
  • Indication for arterial and central-venous line and peridural catheter due to surgery invasiveness
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Lack of written informed consent
  • Insufficient language skills
  • Unwillingness to have pseudonymized disease data stored or anonymized data shared
  • American Society of Anesthesiologists physical status higher than grade 3
  • Congestive heart failure grade 2 or higher according to the New York Heart Association
  • Ischemic cardiopathy grade 2 or higher according to the Canadian Cardiovascular Society
  • Known severe heart valve diseases
  • Chronic kidney disease requiring hemodialysis
  • Atrial fibrillation or atrial flutter
  • Pulmonary hypertension

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Evangelische Kliniken Essen-Mitte

Essen, North Rhine-Westphalia, Germany, 45136

Actively Recruiting

Loading map...

Research Team

A

Aarne Feldheiser, M.D., PhD.

CONTACT

S

Stefan Boland

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here